SYSTEMIC TREATMENT

Clinical trials for SYSTEMIC TREATMENT explained in plain language.

Never miss a new study

Get alerted when new SYSTEMIC TREATMENT trials appear

Sign up with your email to follow new studies for SYSTEMIC TREATMENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for liver transplant patients with recurrent cancer: immunotherapy combo under study

Disease control Recruiting now

This phase 2 trial is testing whether a combination of two drugs, atezolizumab and bevacizumab, can safely treat liver cancer that has come back after a liver transplant. The study includes 50 patients who will receive the drug combo every three weeks along with a strict immunosu…

Matched conditions: SYSTEMIC TREATMENT

Phase: PHASE2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control

Last updated Jun 22, 2026 11:57 UTC

SYSTEMIC TREATMENT

Get alerted when new SYSTEMIC TREATMENT trials appear

New hope for liver transplant patients with recurrent cancer: immunotherapy combo under study